GENEVA, Aug. 18 -- SEAGEN INC. (21823 30th Drive SEBothell, Washington 98021) filed a patent application (PCT/IB2025/051146) for "METHODS OF TREATING CANCERS USING ANTI-CD30 ANTIBODY-DRUG CONJUGATES" on Feb 03, 2025. With publication no. WO/2025/169056, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Tara L. (c/o Seagen Inc.21823 30th Drive SEBothell, Washington 98021)

Abstract: Provided herein are antibody-drug conjugates that bind to CD30 comprising an anti-CD30 antibody or an antigen-binding fragment thereof a...